Anti-apoptotic protein Lifeguard does not act as a tumor marker in breast cancer

The aim of the present study was to use an enzyme-linked immunosorbent assay (ELISA) to determine the concentrations of Lifeguard (LFG) protein in the serum of 36 patients diagnosed with breast cancer and to compare these values with the concentrations of LFG protein in the serum of 7 healthy volunt...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurer, Viktor, Reimers, Kerstin, Lück, Hans J., Vogt, Peter M., Bucan, Vesna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403417/
https://www.ncbi.nlm.nih.gov/pubmed/28454284
http://dx.doi.org/10.3892/ol.2017.5658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403417/
https://www.ncbi.nlm.nih.gov/pubmed/28454284
http://dx.doi.org/10.3892/ol.2017.5658

Ejemplares similares